Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis.
Marchiafava-Bignami disease in chronic alcoholic patient.
Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
Magnetization transfer imaging reveals geniculocalcarine and striate area degeneration in primary glaucoma: a preliminary study.
A Novel Transgenic Mouse Model of Lysosomal Storage Disorder.
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.
Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis.
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature.
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Relationships between trunk performance, gait and postural control in persons with multiple sclerosis.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
OMIP-033: A comprehensive single step staining protocol for human T- and B-cell subsets.
Heterogeneity of astrocyte and NG2 cell insertion at the node of Ranvier.
Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.
Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder.
Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation.
Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1.
Heterogeneous depression trajectories in multiple sclerosis patients.
Knockdown of Unconventional Myosin ID Expression Induced Morphological Change in Oligodendrocytes.
Neurogenic bowel dysfunction translation and linguistic validation to classical Arabic.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NO.
Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.
Pages
« first
‹ previous
…
801
802
803
804
805
806
807
808
809
…
next ›
last »